Protara Therapeutics Inc (TARA)
Healthcare
Biotechnology
4.00 $
+1.3%
vs. previous close
Closing price · As of: 3. Aug 2026
Protara Therapeutics Inc (TARA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -56 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.0 | -18 | -24 | -22 | -23 | -16 | -23 | -35 | -26 | -38 | -36 | -56 | |
| 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.2 | 0.1 | 0.2 | 0.3 | 0.3 | 0.4 | |
| 0.5 | 2.2 | 3.3 | 0.0 | 3.4 | 0.9 | 9.7 | 10 | 6.7 | 6.1 | 4.1 | 3.8 | |
| 0.5 | 2.8 | 3.3 | 3.1 | 3.4 | 0.9 | 9.7 | 12 | 39 | – | – | – | |
| 0.1 | 0.3 | 1.3 | 4.4 | -6.0 | -1.9 | 0.6 | 0.5 | 0.5 | -4.1 | 4.0 | -2.9 | |
| 0.1 | 0.2 | 0.3 | 0.0 | 0.1 | 0.0 | 0.9 | 0.6 | 0.1 | 0.0 | 0.1 | 0.1 | |
| -12 | -11 | 20 | -16 | 18 | 2.5 | 2.8 | -98 | 15 | 53 | 19 | -139 | |
| 89 | 0.2 | 0.2 | 23 | 3.0 | – | 94 | -0.2 | -0.1 | -0.1 | – | – | |
| – | – | – | -1.7 | -1.7 | -1.7 | -1.7 | 0.0 | – | – | – | – | |
| 89 | 0.2 | 0.2 | 23 | 3.0 | 0.5 | 189 | -0.2 | -0.1 | -0.1 | 140 | 83 | |
| 66 | -29 | -3.6 | -15 | -1.8 | -13 | 169 | -133 | -12 | 15 | 123 | -113 | |
| -10 | -18 | -24 | -22 | -23 | -16 | -24 | -35 | -27 | -38 | -36 | -56 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.